Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study

Blood (2023) 142 (17): 1438–1447.

https://doi.org/10.1182/blood.2022019173

Published: 2023

Includes: Supplemental data

Journal Articles

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Blood (2019) 134 (10): 798–801.

https://doi.org/10.1182/blood.2019001088

Published: 2019

Includes: Supplemental data

Journal Articles

Early Progression As a Predictor of Survival in Marginal Zone Lymphomas: An Analysis from the Prospective International NF10 Study By Fondazione Italiana Linfomi

Blood (2018) 132 (Supplement 1): 393.

https://doi.org/10.1182/blood-2018-99-115827

Published: 2018

Journal Articles

Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study

Blood (2017) 130 (Supplement 1): 4062.

https://doi.org/10.1182/blood.V130.Suppl_1.4062.4062

Published: 2017

Journal Articles

Real Life Data on Clinical Aspects and Treatment of Marginal Zone Lymphoma: An Analysis from the NF10 Project, an International, Prospective, Observational Study of the Fondazione Italiana Linfomi

Blood (2017) 130 (Supplement 1): 1493.

https://doi.org/10.1182/blood.V130.Suppl_1.1493.1493

Published: 2017

Journal Articles

The Outcome of Patients with Primary Refractory or Relapsed Peripheral T-Cell Lymphoma: Analysis of 1020 Cases Registered in the Prospective T-Cell Project

Monica Bellei, Francine M Foss, MD, Steven M Horwitz, MD, Luigi Marcheselli, Won Seong Kim, Maria Elena Cabrera, Ivan Dlouhy, MD, Arnon Nagler, Ranjana H Advani, MD, Emanuela Pesce, Young Hyeh Ko, MD, Virginia Martinez, Silvia Montoto, MD, Carlos Chiattone, Alison J. Moskowitz, MD, Michele Spina, Marina Cesaretti, Irene Biasoli, Massimo Federico

Blood (2016) 128 (22): 921.

https://doi.org/10.1182/blood.V128.22.921.921

Published: 2016

Journal Articles

Pattern of Care in Indolent Non Follicular Lymphoma: A Report from NF10 Project, an International, Prospective, Observational Study Coordinated By the Fondazione Italiana Linfomi

Blood (2015) 126 (23): 2686.

https://doi.org/10.1182/blood.V126.23.2686.2686

Published: 2015

Journal Articles

Bendamustine and Rituximab Combination In Untreated Indolent Non Follicular B-Cell Non-Hodgkin's Lymphomas. A Phase II Study From The Fondazione Italiana Linfomi (INFL09)

Stefano Luminari, MD, Maria Cecilia Goldaniga, MD, Marina Cesaretti, Lorella Orsucci, Alessandra Tucci, MD, Alessandro Pulsoni, MD, Flavia Salvi, MD, Angelo Michele Carella, Alessandra Tedeschi, MD, Antonio Pinto, MD, Caterina Stelitano, Daniele Vallisa, MD, Fiorella Ilariucci, MD, Michele Spina, Luca Arcaini, Luigi Marcheselli, MS, Massimo Federico, MD, Luca Baldini

Blood (2013) 122 (21): 3049.

https://doi.org/10.1182/blood.V122.21.3049.3049

Published: 2013

Journal Articles

Final Results Of a Phase II Study Of Lenalidomide In Combination With Rituximab For The Treatment Of Indolent Non Follicular Non Hodgkin Lymphoma

Stefano Sacchi, MD, Samantha Pozzi, MD, Marina Cesaretti, Luigi Marcheselli, MS, Gabriele Buda, MD, Antonio Lazzaro, MD, Luca Baldini, Francesco Di Raimondo, MD, Pellegrino Musto, MD, Alfonso Zaccaria, Giorgina Specchia, Umberto Vitolo, MD, Massimo Magagnoli, MD, Franco Silvestris, MD, Pier Paolo Fattori, MD, Patrizia Tosi, MD, Eliana Valentina Liardo, MD, Alessia Bari, MD, Angelo Michele Carella

Blood (2013) 122 (21): 4383.

https://doi.org/10.1182/blood.V122.21.4383.4383

Published: 2013

Journal Articles

NF10 Project: An International, Prospective, Observational Study Of Patients With Indolent Non-Follicular Lymphoma. Analysis Of First 215 Patients

Luca Arcaini, Stefano Luminari, Marina Cesaretti, Gianluca Gaidano, Sara Rattotti, Michele Merli, Maria Giuseppina Cabras, Michele Spina, Luca Baldini, Alessandra Tedeschi, Lorella Orsucci, Maria Gomes da Silva, Luigi Marcheselli, Torresan Delamein Marcia, Massimo Federico, MD

Blood (2013) 122 (21): 1782.

https://doi.org/10.1182/blood.V122.21.1782.1782

Published: 2013

Journal Articles

Results of a Phase II Study of Lenalidomide in Combination with Rituximab for the Treatment of Indolent Non Follicular Non Hodgkin Lymphoma (NHL)

Stefano Sacchi, Samantha Pozzi, Marina Cesaretti, Luigi Marcheselli, Eliana Valentina Liardo, Gabriele Buda, Antonio Lazzaro, Luca Baldini, Francesco Di Raimondo, MD, Pellegrino Musto, Alfonso Zaccaria, Giorgina Specchia, Umberto Vitolo, Massimo Magagnoli, Franco Silvestris, Pier Paolo Fattori, Patrizia Tosi, Angelo Michele Carella

Blood (2012) 120 (21): 1645.

https://doi.org/10.1182/blood.V120.21.1645.1645

Published: 2012

Journal Articles

The Outcome of T-Cell Lymphoma Patients Failing First-Line Treatment: Results of a Population Based-Study From the Modena Cancer Registry

Irene Biasoli, Marina Cesaretti, Stefano Luminari, Monica Bellei, Alessandra Dondi, Emanuela Anna Pesce, Stefania Badiali, Micol Quaresima, Maria Angela Sirotti, Massimo Federico

Blood (2012) 120 (21): 1611.

https://doi.org/10.1182/blood.V120.21.1611.1611

Published: 2012

Journal Articles

Addition of Rituximab to Front-Line-Treatment Highly Improved the Outcome of Elderly Patients with Follicular Lymphoma: a Population Based-Study From the Modena Cancer Registry

Stefano Luminari, Irene Biasoli, Luigi Marcheselli, Monica Bellei, Alessandra Dondi, Sonia Mastronardi, Marina Cesaretti, Massimo Federico

Blood (2012) 120 (21): 5077.

https://doi.org/10.1182/blood.V120.21.5077.5077

Published: 2012

Journal Articles

Use of FDG Positron Emission Tomography (FDG-PET) in Patients with Hodgkin Lymphoma (HL): a Population Based Study.

Stefano Luminari, Marina Cesaretti, Stefano Madrigali, Bruno Bagni, Francesco Merli, Lucia Mangone, Annibale Versari, Francesca Re, Vincenzo De Lisi, Livia Ruffini, Stefano Ferretti, Antonio Cuneo, Massimo Federico

Blood (2009) 114 (22): 5023.

https://doi.org/10.1182/blood.V114.22.5023.5023

Published: 2009

Journal Articles

Incidence Clinical Characteristics and Survival of Non Splenic Marginal Zone Lymphomas: A Population Based Study from a Cancer Registry in Northern Italy

Stefano Luminari, MD, Ivan Rashid, Marina Cesaretti, Luigi Marcheselli, Alessandra Dondi, Stefano Madrigali, Gianluca Cervo, Monica Bellei, Antonella Montanini, Caterina Mammi, Maria Angela Sirotti, Massimo Federico, MD

Blood (2008) 112 (11): 3753.

https://doi.org/10.1182/blood.V112.11.3753.3753

Published: 2008

Journal Articles

Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study

Emilio Iannitto, MD, Stefano Luminari, MD, Caterina Mammi, MD, Viviana Minardi, Francesco Merli, MD, Francesco Angrilli, MD, Caterina Stelitano, MD, Marina Cesaretti, Giovanni Franco, MD, Angelo M. Carella, MD, Massimo Federico, MD

Blood (2007) 110 (11): 1293.

https://doi.org/10.1182/blood.V110.11.1293.1293

Published: 2007

Journal Articles

Incidence, Clinical Characteristics and Survival of Malignant Lymphomas in the Province of Modena (Italy); a Population-Based Study.

Stefano Luminari, Marina Cesaretti, Ivan Rashid, Elsa Pennese, Caterina Mammi, Antonella Montanini, Elisa Barbolini, Monica Bellei, Luigi Marcheselli, Giovanni Partesotti, Alessia Bari, Antonio Maiorana, Tullio Artusi, Massimo Federico

Blood (2006) 108 (11): 4628.

https://doi.org/10.1182/blood.V108.11.4628.4628

Published: 2006

NARROW

Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Early Progression As a Predictor of Survival in Marginal Zone Lymphomas: An Analysis from the Prospective International NF10 Study By Fondazione Italiana Linfomi

Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study

Real Life Data on Clinical Aspects and Treatment of Marginal Zone Lymphoma: An Analysis from the NF10 Project, an International, Prospective, Observational Study of the Fondazione Italiana Linfomi

The Outcome of Patients with Primary Refractory or Relapsed Peripheral T-Cell Lymphoma: Analysis of 1020 Cases Registered in the Prospective T-Cell Project

Pattern of Care in Indolent Non Follicular Lymphoma: A Report from NF10 Project, an International, Prospective, Observational Study Coordinated By the Fondazione Italiana Linfomi

Bendamustine and Rituximab Combination In Untreated Indolent Non Follicular B-Cell Non-Hodgkin's Lymphomas. A Phase II Study From The Fondazione Italiana Linfomi (INFL09)

Final Results Of a Phase II Study Of Lenalidomide In Combination With Rituximab For The Treatment Of Indolent Non Follicular Non Hodgkin Lymphoma

NF10 Project: An International, Prospective, Observational Study Of Patients With Indolent Non-Follicular Lymphoma. Analysis Of First 215 Patients

Results of a Phase II Study of Lenalidomide in Combination with Rituximab for the Treatment of Indolent Non Follicular Non Hodgkin Lymphoma (NHL)

The Outcome of T-Cell Lymphoma Patients Failing First-Line Treatment: Results of a Population Based-Study From the Modena Cancer Registry

Addition of Rituximab to Front-Line-Treatment Highly Improved the Outcome of Elderly Patients with Follicular Lymphoma: a Population Based-Study From the Modena Cancer Registry

Use of FDG Positron Emission Tomography (FDG-PET) in Patients with Hodgkin Lymphoma (HL): a Population Based Study.

Incidence Clinical Characteristics and Survival of Non Splenic Marginal Zone Lymphomas: A Population Based Study from a Cancer Registry in Northern Italy

Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study

Incidence, Clinical Characteristics and Survival of Malignant Lymphomas in the Province of Modena (Italy); a Population-Based Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only